Delivery Order SPE2DB20D6036-SPE2DB24FC8PH

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML medical products. The contract has a ceiling value of $2,249.67 and a completion date of May 2, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,469.06, is for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,781.70 order is for DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product, with a ceiling value of $2,479.26. The contract has an ultimate completion date of August 14, 2024 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML, with a ceiling value of $1,243.59 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,973.24 and is a firm fixed-price delivery order type. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,094.67, is a delivery order for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,643.78, is for the delivery of DURAMORPH 10 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a firm-fixed price pricing type and a completion date of June 11, 2025. The award is not set-aside and represents open competition. AmerisourceBergen Drug Corp also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Duramorph 5 mg/10 mL ampule 10 mL, with a ceiling value of $2,624.64 and a completion date of July 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DURAMORPH 10 MG/10 ML AMPUL 10ML, a medical product. The contract has a ceiling value of $1,898.54 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D6036
    Indefinite Delivery Contract
  • SPE2DB20D6036-SPE2DB24FC8PH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,234.94, is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a prescription opioid medication. The contract is a firm fixed-price arrangement with a completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999 through December 2025, for providing a broad range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 10/31/24, 10:29 AM